AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12706319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10690137 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable pitch pulse oximeter
Number of subjects: 30
Study 10690137 — intervention group
Group type: COMPARATOR
Intervention: Fixed pitch pulse oximeter
Number of subjects: 30
Study 8942116 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual mnemonic device using a distinctive plastic plate
Number of subjects: 0
Study 8942116 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 1754607 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam (4.8 g daily for 6 weeks)
Number of subjects: 101
Study 1754607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 1754607 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 101
Study 7073918 — intervention group
Group type: EXPERIMENTAL
Intervention: Trendelenberg position
Number of subjects: 20
Study 7073918 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 20
Study 30731334 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiotocography with fetal ECG ST-segment analysis (ECG-F group)
Number of subjects: 200
Study 30731334 — intervention group
Group type: COMPARATOR
Intervention: Cardiotocography alone (CTG group)
Number of subjects: 200
Study 28420417 — intervention group
Group type: EXPERIMENTAL
Intervention: Early image group (received future self-image at recruitment)
Number of subjects: 145
Study 28420417 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed image group (received future self-image after 8 weeks)
Number of subjects: 145
Study 28420417 — intervention group
Group type: COMPARATOR
Intervention: Second image group (received an additional future self-image at 16 weeks)
Number of subjects: 145
Study 28420417 — intervention group
Group type: COMPARATOR
Intervention: No additional image group (did not receive an additional future self-image at 16 weeks)
Number of subjects: 145
Study 26147316 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Story Memory Technique (mSMT)
Number of subjects: 18
Study 26147316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 23732552 — intervention group
Group type: EXPERIMENTAL
Intervention: Jerte Valley cherry‐based product (JVCP)
Number of subjects: 30
Study 23732552 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Kool‐Aid®)
Number of subjects: 30
Study 21970852 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib (oral antiepidermal growth factor receptor tyrosine kinase inhibitor)
Number of subjects: 1942
Study 19894376 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese decoction, ligustrazin hydrochloride injection, and He‐Ne laser therapy
Number of subjects: 90
Study 19894376 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E and Vitamin C plus external application of 20% Azelaic acid cream
Number of subjects: 90
Study 17040925 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% albumin
Number of subjects: 6045
Study 17040925 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 6045
Study 12719047 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.25% (10 mL) and morphine 0.1% (2 mL) as a bolus followed by an infusion of bupivacaine 0.25% plus morphine 0.025% (5 mL/hr)
Number of subjects: 40
Study 12719047 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine 0.25% (10 mL) and saline 0.9% (2 mL) as a bolus followed by an infusion of bupivacaine 0.25% (5 mL/hr)
Number of subjects: 40
Study 10750913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous (IO) procedure
Number of subjects: 42
Study 10750913 — intervention group
Group type: COMPARATOR
Intervention: Umbilical venous catheterization (UVC) procedure
Number of subjects: 42
Study 9010708 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg daily for 4 days
Number of subjects: 10
Study 9010708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 1291405 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg p.o. omeprazole
Number of subjects: 8
Study 1291405 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg i.v. omeprazole
Number of subjects: 8
Study 1291405 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg i.v. omeprazole
Number of subjects: 8
Study 6698373 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (2600 mg orally 1 hour before aspirin or ethanol)
Number of subjects: 5
Study 6698373 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (1300 mg) or Ethanol (20% vol/vol)
Number of subjects: 5
Study 6698373 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (50 mg orally 12 hours and 1 hour before acetaminophen)
Number of subjects: 5
Study 6698373 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin alone
Number of subjects: 5
Study 30822612 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism adaptation to a leftward optical deviation
Number of subjects: 0
Study 30822612 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 30566006 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9338
Study 30566006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9338
Study 29101447 — intervention group
Group type: EXPERIMENTAL
Intervention: Short video intervention
Number of subjects: 254
Study 29101447 — intervention group
Group type: EXPERIMENTAL
Intervention: Seminar involving direct contact with a service user
Number of subjects: 254
Study 29101447 — intervention group
Group type: COMPARATOR
Intervention: Informational leaflet
Number of subjects: 254
Study 26267853 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacing the existing lens with a new lens
Number of subjects: 30
Study 26267853 — intervention group
Group type: EXPERIMENTAL
Intervention: Removing and reapplying the same lens
Number of subjects: 30
Study 26267853 — intervention group
Group type: EXPERIMENTAL
Intervention: Performing a 'scleral swish'
Number of subjects: 30
Study 26267853 — intervention group
Group type: COMPARATOR
Intervention: No action (control)
Number of subjects: 30
Study 24006504 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirarubicin instillation
Number of subjects: 108
Study 24006504 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 108
Study 21934487 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 159
Study 21934487 — intervention group
Group type: COMPARATOR
Intervention: Endovenous laser therapy (EVLT)
Number of subjects: 159
Study 21934487 — intervention group
Group type: COMPARATOR
Intervention: Both RFA and EVLT
Number of subjects: 159
Study 19146517 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-worth therapy (30 minutes, once a week for 4 weeks)
Number of subjects: 63
Study 19146517 — intervention group
Group type: COMPARATOR
Intervention: Control group (no therapy, 30 minutes of chatting once a week for 4 weeks)
Number of subjects: 63
Study 19146517 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-worth therapy
Number of subjects: 63
Study 16446080 — intervention group
Group type: COMPARATOR
Intervention: Regular environmental conditions (20.2 degrees C, 40% relative humidity)
Number of subjects: 20
Study 16446080 — intervention group
Group type: EXPERIMENTAL
Intervention: Humid environmental conditions (19.9 degrees C, 95% relative humidity)
Number of subjects: 20
Study 14578394 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse geometry design CRT (Dk=100) rigid lenses
Number of subjects: 20
Study 14578394 — intervention group
Group type: COMPARATOR
Intervention: Alignment tricurve rigid lens (control)
Number of subjects: 20
Study 14578394 — intervention group
Group type: COMPARATOR
Intervention: Control lens
Number of subjects: 20
Study 14578394 — intervention group
Group type: EXPERIMENTAL
Intervention: Test lens
Number of subjects: 20
Study 10784481 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 g/day of glycine added to clozapine
Number of subjects: 30
Study 10784481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 9075807 — intervention group
Group type: EXPERIMENTAL
Intervention: N(G)-monomethyl-L-arginine (NO-synthase inhibitor)
Number of subjects: 20
Study 9075807 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (NO precursor)
Number of subjects: 20
Study 9075807 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 20
Study 8491275 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinusoidal treadmill movement at frequencies of 0.5, 0.3, and 0.25 Hz with a constant amplitude of +/- 12 cm.
Number of subjects: 0
Study 8491275 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinusoidal treadmill movement with eyes open or closed.
Number of subjects: 0
Study 3703632 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk supplemented with human milk protein (0.9 g/dL)
Number of subjects: 44
Study 3703632 — intervention group
Group type: COMPARATOR
Intervention: Plain human milk (control group)
Number of subjects: 44
Study 3703632 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk supplemented with medium-chain triglycerides (1 g/dL)
Number of subjects: 44
Study 3703632 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk supplemented with both protein and medium-chain triglycerides
Number of subjects: 44
Study 3703632 — intervention group
Group type: COMPARATOR
Intervention: Human milk without protein supplementation
Number of subjects: 44
Study 3703632 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk supplemented with protein
Number of subjects: 44
Study 3703632 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum albumin concentration correlation with weight gain
Number of subjects: 44
Study 31982090 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with congenital diaphragmatic hernia (CDH)
Number of subjects: 0
Study 31982090 — intervention group
Group type: COMPARATOR
Intervention: Controls (randomly selected children without CDH)
Number of subjects: 0
Study 31982090 — intervention group
Group type: EXPERIMENTAL
Intervention: Female cases with CDH
Number of subjects: 0
Study 31982090 — intervention group
Group type: EXPERIMENTAL
Intervention: Males with CDH
Number of subjects: 0
Study 31982090 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with CDH
Number of subjects: 0
Study 29722893 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep restriction (6 hr time in bed)
Number of subjects: 35
Study 29722893 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep extension (10 hr time in bed)
Number of subjects: 35
Study 29722893 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sleep deprivation
Number of subjects: 35
Study 27579509 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed motivational, individually tailored postcards (n = 54)
Number of subjects: 117
Study 27579509 — intervention group
Group type: EXPERIMENTAL
Intervention: No postcards (n = 63)
Number of subjects: 117
Study 27579509 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 64)
Number of subjects: 117
Study 24679395 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care programme
Number of subjects: 338
Study 24679395 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 338
Study 22353807 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane after 2-3 years of tamoxifen
Number of subjects: 582
Study 22353807 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 582
Study 20181785 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional advice alone
Number of subjects: 295
Study 20181785 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional advice plus vouchers for fruits and vegetables
Number of subjects: 295
Study 20181785 — intervention group
Group type: COMPARATOR
Intervention: Control group (Nutritional advice alone)
Number of subjects: 295
Study 18394770 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular implant overdentures (IODs)
Number of subjects: 256
Study 18394770 — intervention group
Group type: COMPARATOR
Intervention: Conventional dentures (CDs)
Number of subjects: 256
Study 16007391 — intervention group
Group type: EXPERIMENTAL
Intervention: Active smoking
Number of subjects: 8
Study 16007391 — intervention group
Group type: COMPARATOR
Intervention: Sham smoking
Number of subjects: 8
Study 12771115 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT group (ICD activated, CRT on)
Number of subjects: 369
Study 12771115 — intervention group
Group type: COMPARATOR
Intervention: Control group (ICD activated, CRT off)
Number of subjects: 369
Study 12771115 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 369
Study 10907343 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of bifonazole (Mycospor cream) + 10% urea ointment (Urepearl) (group I)
Number of subjects: 0
Study 10907343 — intervention group
Group type: COMPARATOR
Intervention: Occlusive dressing therapy with bifonazole (Mycospor cream) + 10% urea ointment (Urepearl) (group II)
Number of subjects: 0
Study 8054072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent transdermal application of nitroglycerin (15 hours/day)
Number of subjects: 12
Study 8054072 — intervention group
Group type: COMPARATOR
Intervention: Continuous transdermal application of nitroglycerin (24 hours/day)
Number of subjects: 12
Study 2681872 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole brain irradiation (40 Gy)
Number of subjects: 49
Study 2681872 — intervention group
Group type: COMPARATOR
Intervention: Local irradiation (total 56 Gy/28 f/6 weeks)
Number of subjects: 49
Study 770083 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg azapropazone per day
Number of subjects: 50
Study 770083 — intervention group
Group type: COMPARATOR
Intervention: 100 mg indomethacin per day
Number of subjects: 50
Study 31386163 — intervention group
Group type: EXPERIMENTAL
Intervention: ItchyQoL questionnaire
Number of subjects: 130
Study 28279433 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower oxygen saturation target (85‐89%)
Number of subjects: 1054
Study 28279433 — intervention group
Group type: COMPARATOR
Intervention: Higher oxygen saturation target (91%‐95%)
Number of subjects: 1054
Study 28279433 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower achieved oxygen saturation (≤92%)
Number of subjects: 1054
Study 28279433 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased incidence of intermittent hypoxemia events
Number of subjects: 1054
Study 26208959 — intervention group
Group type: EXPERIMENTAL
Intervention: Bapineuzumab 0.5 mg/kg
Number of subjects: 154
Study 26208959 — intervention group
Group type: EXPERIMENTAL
Intervention: Bapineuzumab 1.0 mg/kg
Number of subjects: 154
Study 26208959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 23599046 — intervention group
Group type: EXPERIMENTAL
Intervention: D-Cycloserine (50 mg before each of five exposure sessions)
Number of subjects: 169
Study 23599046 — intervention group
Group type: COMPARATOR
Intervention: Placebo (before each of five exposure sessions)
Number of subjects: 169
Study 23599046 — intervention group
Group type: EXPERIMENTAL
Intervention: D-Cycloserine
Number of subjects: 169
Study 23599046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study 20648212 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Number of subjects: 0
Study 20648212 — intervention group
Group type: COMPARATOR
Intervention: Lumbar intraarticular facet joint injections
Number of subjects: 0
Study 20648212 — intervention group
Group type: COMPARATOR
Intervention: Lumbar interlaminar epidural injections
Number of subjects: 0
Study 20648212 — intervention group
Group type: COMPARATOR
Intervention: Caudal epidural steroids for conditions other than disc herniation or radiculitis
Number of subjects: 0
Study 20648212 — intervention group
Group type: COMPARATOR
Intervention: Sacroiliac joint injections
Number of subjects: 0
Study 20648212 — intervention group
Group type: COMPARATOR
Intervention: Intradiscal electrothermal therapy
Number of subjects: 0
Study 20648212 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic adhesiolysis
Number of subjects: 0
Study 20648212 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal therapy
Number of subjects: 0
Study 20648212 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic lumbar facet joint nerve blocks
Number of subjects: 0
Study 20648212 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural injections in disc herniation or radiculitis
Number of subjects: 0
Study 20648212 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous adhesiolysis in post lumbar surgery syndrome
Number of subjects: 0
Study 20648212 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency neurotomy
Number of subjects: 0
Study 20648212 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal epidural injections in radiculitis
Number of subjects: 0
Study 17901215 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician communication behaviors (careful listening, inquiring about at-home management, nonverbal attention, interactive conversation, tailoring short-term goals, long-term therapeutic plan)
Number of subjects: 452
Study 17901215 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician communication behaviors (interactive conversation, short-term goals, criteria for decision making, long-term treatment plan, tailoring according to needs)
Number of subjects: 452
Study 16616235 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated D-dimer (highest tertile)
Number of subjects: 332
Study 16616235 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline D-dimer
Number of subjects: 332
Study 16616235 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CRP (highest tertile)
Number of subjects: 332
Study 16616235 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary end point (composite of ABI progression, CDS progression, stroke, myocardial infarction, amputation, and death from cardiovascular disease)
Number of subjects: 332
Study 16616235 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline D-dimer and CRP
Number of subjects: 332
Study 14526281 — intervention group
Group type: EXPERIMENTAL
Intervention: Scripted verbal query
Number of subjects: 0
Study 14526281 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed written permission slip
Number of subjects: 0
Study 14526281 — intervention group
Group type: COMPARATOR
Intervention: Control group (current practice)
Number of subjects: 0
Study 10868720 — intervention group
Group type: EXPERIMENTAL
Intervention: Le Bon Départ treatment
Number of subjects: 6
Study 10868720 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory Integration treatment
Number of subjects: 6
Study 10868720 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 6
Study 10868720 — intervention group
Group type: COMPARATOR
Intervention: Treatment 1
Number of subjects: 6
Study 10868720 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment 2
Number of subjects: 6
Study 9106374 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline for 6 weeks (with possible adjunctive lithium)
Number of subjects: 101
Study 9106374 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine for 6 weeks (with possible lithium augmentation)
Number of subjects: 101
Study 9106374 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy or fluoxetine for 6 weeks (with possible lithium augmentation)
Number of subjects: 101
Study 9106374 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment response
Number of subjects: 101
Study 1583265 — intervention group
Group type: EXPERIMENTAL
Intervention: Allen figure
Number of subjects: 34
Study 1583265 — intervention group
Group type: EXPERIMENTAL
Intervention: Broken Wheel
Number of subjects: 34
Study 3896663 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivampicillin (500 mg or 1 g twice daily)
Number of subjects: 43
Study 3896663 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin (250 mg or 500 mg 3-times daily)
Number of subjects: 43
Study 3896663 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 43
Study 31429514 — intervention group
Group type: EXPERIMENTAL
Intervention: Iyengar yoga
Number of subjects: 27
Study 31429514 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking program
Number of subjects: 27
Study 26919833 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg/day) and Naoxintong Capsule (1.6 g thrice a day)
Number of subjects: 151
Study 26919833 — intervention group
Group type: COMPARATOR
Intervention: Adjusted-dose warfarin (international normalized ratio 2.0-3.0)
Number of subjects: 151
Study 26919833 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin combined with NXT and warfarin
Number of subjects: 151
Study 27511181 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus treatment (titrated to trough levels of 5-10 ng/mL)
Number of subjects: 23
Study 27511181 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus treatment (for children who reached target trough levels)
Number of subjects: 23
Study 27511181 — intervention group
Group type: COMPARATOR
Intervention: Standard-care period
Number of subjects: 23
Study 27511181 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive development
Number of subjects: 23
Study 27511181 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 23
Study 24652518 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab or Bevacizumab treatment
Number of subjects: 835
Study 22972872 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers (metoprolol)
Number of subjects: 153
Study 22972872 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 153
Study 22972872 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled analysis of β-blockers
Number of subjects: 153
Study 19819079 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone administration
Number of subjects: 16
Study 19819079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 18008230 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir at 500 mg twice daily
Number of subjects: 20
Study 18008230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 16238910 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial Fibrillation (AFIB) patients
Number of subjects: 3944